Professor Jasper Fuk-Woo Chan is currently Assistant Dean (Global Engagement) of the Li Ka Shing Faculty of Medicine, The University of Hong Kong (HKU); Deputy Department Chairperson and tenured Clinical Professor, Department of Microbiology, HKU; Deputy Chief-of-Service and Consultant, Department of Infectious Diseases and Microbiology, HKU-Shenzhen Hospital; and Honorary Consultant, Department of Microbiology, Queen Mary Hospital. He received his M.B.B.S. from HKU in 2005 and underwent postgraduate specialist training at the Department of Medicine and Department of Microbiology at Queen Mary Hospital to become Fellow of the Royal Colleges of Physicians of Edinburgh and Glasgow, the Royal College of Pathologists of the United Kingdom, the Hong Kong College of Pathologists, and the Hong Kong Academy of Medicine. He joined the Department of Microbiology at his alma mater as Clinical Assistant Professor in 2013 and became Clinical Professor in 2024. He was awarded the Sir Patrick Manson Gold Medal for the best M.D. thesis at HKU in 2017. He was elected as Fellow of the Infectious Diseases Society of America (FIDSA) in 2022 and as Member of the Hong Kong Young Academy of Sciences in 2024.

Professor Chan's research focuses on the diagnosis, treatment, and control of emerging viral infections with pandemic potential and emerging infectious diseases with special relevance to Asia. He has authored more than 350 journal publications in these areas (Scopus: h-index 85, citations: >42,000), including (co-)first/corresponding-authored publications in The Lancet, Science, and Nature. Professor Chan has been consistently ranked by Clarivate as one of the world's top 1% scholars by citations since 2015 and as a "Highly Cited Researcher" (2 fields: "Microbiology" and "Immunology")  since 2021. He has served as expert member or ambassador of various international organizations, including member of the WHO ad hoc Expert Group focused on COVID-19 disease modelling (WHOCOM) and Young Ambassador of Science of the American Society for Microbiology. He has been invited to chair sessions or speak at more than 70 international and regional conferences/symposia. He is an Associate Editor / Editorial Advisory Board / Global Advisory Board Member for Clinical Microbiology Reviews, American Journal of Transplantation, Journal of Medical Virology, Open Forum Infectious Diseases, Pathogens, and BMC Microbiology, and has been invited to review research papers for more than 50 journals (including NEJM, The Lancet, and Nature series) and grant applications for international/national funding agencies in USA and Europe [European Research Council (ERC), Switzerland (SNSF), France (ANR), the Netherlands (NWO), Austria (FWF), Poland (NCN), and Croatia (HRZZ)]. He has obtained various external peer-reviewed research grants as Principal Coordinator/Investigator (MoST, NSFC, RGC-CRF & GRF, and HMRF) and own a number of patents on novel diagnostics and antivirals. He has received a number of research awards, including the State Scientific and Technological Progress Award (Second-class Award, 2019), RGC Research Fellow Scheme (2024-25), Gold and Silver Medals at the Geneva International Exhibition of Inventions (2023 & 2024), the 8th VCANBIO Award for Biosciences and Medicine (Innovation Breakthrough Award) (2023), HKU Outstanding Young Researcher Award (2020-21), HKU Research Output Prize (4 years: 2015-16, 2020-21, 2021-22 & 2022-23), Prize for Best Original Research by Young Fellows of the Hong Kong Academy of Medicine (Gold Medal) (2021), Biomedicines Young Investigator Award (2021), Pathogens Young Investigator Award (2021), Emerging Microbes & Infections Best Paper Award (2020), Lo Ying Shek Chi Wai Foundation Award for Young Investigator (2020), the Health and Medical Reserach Fund Most Promising Young Researcher Award (2019), the Best Poster Award (Young Investigator Category at the 32^nd International Conference on Antiviral Research by International Society for Antiviral Research, 2019), and the Chinese Medical Science and Technology Award (Second-class Award, Chinese Medical Association, 2018).

Professor Chan and his team reported the world’s first familial cluster of COVID-19 that confirmed person-to-person transmission of SARS-CoV-2 in January 2020, which resulted in major policy changes for controlling the pandemic worldwide (Chan JF et al., Lancet 2020). This paper was selected by The Lancet as 1 of 34 articles highlighted in the “200 years of The Lancet” timeline. His team also established the world’s first golden Syrian hamster model for COVID-19, which has now become one of the most commonly used animal models for COVID-19 research.

陳福和教授現為香港大學李嘉誠醫學院助理院長(環球拓展), 微生物學系副系主任及臨床教授, 香港大學深圳醫院感染性疾病醫學部副主管及顧問醫生, 及香港瑪麗醫院微生物科名譽顧問醫生。陳教授於2005年畢業於香港大學並獲香港大學內外全科醫學士學位。 2006年至2012年，他於瑪麗醫院內科學系及微生物科學系接受專科醫生培訓，並成為英國愛丁堡皇家內科醫學院榮授院士、英國格拉斯哥皇家醫學院內科榮授院士、英國皇家病理科醫學院榮授院士、香港病理學專科學院院士及香港醫學專科學院院士。 陳教授於2013年加入香港大學李嘉誠醫學院微生物學系擔任臨床助理教授, 並於2024年晉升為臨床教授。2017年，他考獲香港大學醫學博士學位並獲授白文信爵士金牌（香港大學醫學博士學位應屆最佳畢業論文）。2022年，他當選為美國感染及傳染病學會院士。2024年，他當選為香港青年科學院院士。

陳教授的主要研究方向是有全球大流行潛力的新興病毒感染及與亞洲有特別相關性的新發傳染病的診斷, 治療和控制。他已在SCI收錄國際同行評審學術刊物上發表學術論著及綜述350餘篇, 包括以第一作者或通訊作者(含共同)身分在《柳葉刀》、《科學》和《自然》等頂尖學術期刊發表數篇論文 (Scopus: h-index: 85, 被引用次數: >42,000次)。根據科睿唯安, 自2015年起他每年均被列為“全球被引用最多的1%學者”, 以及自2021年起被列為 "全球高被引學者" (2個特定領域: "微生物學" 和 "免疫學") 。他曾擔任不同國際組織的專家成員或大使, 包括世界衛生組織專注於 COVID-19 疾病建模的特設專家組 (WHOCOM)和美國微生物學會的青年科學大使(香港)。陳教授曾被邀請在超過70個國際性和區域性會議上主持會議或演講。他現為 Clinical Microbiology Reviews, American Journal of Transplantation, Journal of Medical Virology, Open Forum Infectious Diseases, Pathogens, 及 BMC Microbiology 的副主編 / 編輯顧問委員會成員 / 全球顧問委員會成員。他曾受邀為50餘種期刊（包括《新英格蘭醫學雜誌》、《柳葉刀》和《自然》系列）審閱研究論文，並為美國和歐洲 [歐洲研究委員會 (ERC)、瑞士(SNSF)、法國(ANR)、荷蘭(NWO)、奧地利(FWF)、波蘭(NCN) 和克羅地亞(HRZZ)] 等國際/國家資助機構審閱資助申請。他作為主要負責人獲得多項國家及香港特別行政區的研究基金項目(國家重點研發計劃,國家自然科學基金,香港特別行政區研資局協作研究金和優配研究金,香港特別行政區醫療衛生研究基金等) 及國內外的專利。此外, 他也獲得了多項國際性和區域性獎項 [例如: 國家科學技術進步獎(二等獎) (2019), 研資局研究學者計劃 (2024-25), 日內瓦國際發明展金獎和銀獎 (2023 & 2024), 第八屆中源協和生命醫學獎 (創新突破獎) (2023), 香港大學傑出青年研究學者獎 (2020-21), 香港大學研究成果獎 (4年: 2015-16, 2020-21, 2021-22 及 2022-23), 香港醫學專科學院年青院士最佳原創研究獎(金牌) (2021), Biomedicines 年青研究員獎 (2021), Pathogens 年青研究員獎 (2021), Emerging Microbes & Infections 最佳論文獎 (2020), 羅鷹石慈慧基金傑出年青研究獎 (2020), 香港特別行政區醫療衛生研究基金最傑出年青研究員獎 (2019), 第 32 屆國際抗病毒研究會議青年研究者組最佳牆報獎 (2019), 中華醫學科技獎(二等獎) (2018) 等]。

陳教授和他的團隊在2020年1月報告了全球第一個2019冠狀病毒病家族聚集性病例，證實了新冠病毒在人與人之間的傳播，這導致控制全球大流行的政策發生重大變化。該論文獲選《柳葉刀》200年來具里程碑地位論文 (全國僅三篇論文獲選)。他的團隊亦建立了全球首個2019冠狀病毒病的敘利亞倉鼠模型，該模型現已成為 2019冠狀病毒病研究中最常用的動物模型之一。